The results of a comprehensive next-generation sequencing panel test (FoundationOne CDx® Cancer Genomic Profile) of a formalin-fixed paraffin-embedded surgical specimen indicated that the tumor harbored ETV6–NTRK3 fusion. The gene discussed is NTRK3; the disease is neoplasm.